You may be trying to access this site from a secured browser on the server. Please enable scripts and reload this page.
Turn on more accessible mode
Turn off more accessible mode
Skip Ribbon Commands
Skip to main content
Turn off Animations
Turn on Animations
SharePoint
Sign In
Follow
ECC-PICO
Currently selected
SEERS
2019 Cape Town Meeting Documents
PublicComment
It looks like your browser does not have JavaScript enabled. Please turn on JavaScript and try again.
Libraries
2018 Chicago Meeting Documents
2017 ILCOR Anaheim Meeting Documents
PICO Search Re-runs
2017 ILCOR Adelaide Meeting Documents
Evidence Review Process
Newcastle
Lists
Recent
Currently selected
ILCOR 2019 Cape Town Meeting Documents
2018 Chicago Meeting Documents
Feedback
If you have any comments or questions on this page, please email us at:
ILCORC2015@heart.org
Analysis of rhythm during chest compression
Question Type:
Intervention
Digital Worksheet:
Open the Digital Worksheet to find more information on the development of this CoSTR.
Full Question:
Among adults and children who are in cardiac arrest in any setting (P), does analysis of cardiac rhythm during chest compressions (I), compared with standard care (analysis of cardiac rhythm during pauses in chest compressions) (C), change Survival with Favorable neurological/functional outcome at discharge, 30 days, 60 days, 180 days AND/OR 1 year, Survival only at discharge, 30 days, 60 days, 180 days AND/OR 1 year, ROSC, time to first shock, time to commence CPR, CPR quality (O)?
Consensus on Science:
There are currently no human studies that address the identified critical outcomes criteria of favorable neurologic outcome, survival, or ROSC or the important outcomes criteria of CPR quality, time to commencing CPR, or time to first shock.
Treatment Recommendation:
We suggest against the introduction of artifact-filtering algorithms for analysis of electrocardiographic rhythm during CPR unless as part of a research program. We suggest that where EMS systems have already integrated artifact-filtering algorithms into clinical practice, it is reasonable to continue with their use. Values, Preferences, and Task Force Insights In making this recommendation, we placed priority on avoiding the costs of introducing a new technology where the effectiveness or harm on patient outcomes remains to be determined. Where such technologies have already been implemented, we place priority on avoiding the likely costs and inconvenience of their withdrawal from practice. We encourage such systems to report on their experiences to build the evidence base regarding the use of these technologies in clinical practice.
CoSTR Attachments:
PICO Grade 3.pdf
PICOGRADE 2.doc
Contact Us
If you have any comments or questions on this page, please email us at:
ILCORC2015@heart.org